Locoregional treatment of the primary tumor in patients with de novo stage IV breast cancer: a radiation oncologist's perspective
SH Choi, JW Kim, J Choi, J Sohn, SI Kim, S Park… - Clinical breast …, 2018 - Elsevier
Background The aim of this study was to assess the outcomes of patients with de novo stage
IV breast cancer after locoregional treatment (LRT) of primary site. Patients and Methods We
studied 245 patients diagnosed with de novo stage IV breast cancer. LRT of the primary
tumor (+ systemic therapy) was performed in 82 (34%) patients (surgery, 27; surgery+
radiotherapy (RT), 46; and RT, 9). Among those undergoing surgery, 64 (88%) patients
underwent mastectomy, and 9 (12%) patients underwent breast-conserving surgery (BCS) …
IV breast cancer after locoregional treatment (LRT) of primary site. Patients and Methods We
studied 245 patients diagnosed with de novo stage IV breast cancer. LRT of the primary
tumor (+ systemic therapy) was performed in 82 (34%) patients (surgery, 27; surgery+
radiotherapy (RT), 46; and RT, 9). Among those undergoing surgery, 64 (88%) patients
underwent mastectomy, and 9 (12%) patients underwent breast-conserving surgery (BCS) …
